Rachid Massaad

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Long‐Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial

Kathryn M. Connor, Sheena K. Aurora, Tom Loeys et al. · Headache The Journal of Head and Face Pain · 2010 · 84 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia

D. Meeike Kusters, Maria Caceres, Mauricio Coll et al. · The Journal of Pediatrics · 2015 · 76 citations

Pharmacy, Pediatrics, Pharmacotherapy +9

Safety and Efficacy of Ezetimibe Added on to Rosuvastatin 5 or 10 mg Versus Up-Titration of Rosuvastatin in Patients With Hypercholesterolemia (the ACTE Study)

Harold Bays, Michael H. Davidson, Rachid Massaad et al. · The American Journal of Cardiology · 2011 · 74 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study

Michel Farnier, Maurizio Averna, Luc Missault et al. · International Journal of Clinical Practice · 2009 · 69 citations · Full text

Pharmacy, Pharmacotherapy, Cardiovascular Pharmacotherapy +11